Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings-Reference-Cited by-同舟云学术

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings

Published:2014-10-07 Issue:10 Volume:9 Page:e109148
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Phillips Andrew,Cambiano Valentina,Nakagawa Fumiyo,Magubu Travor,Miners Alec,Ford Debbie,Pillay Deenan,De Luca Andrea,Lundgren Jens,Revill Paul

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. WHO (2013) Global update on HIV treatment 2013: Results, impact and opportunities.

2. WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach.

3. Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials;R Gupta;Clin Infect Dis,2008

4. Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch;V Johnston;J Infect Dis,2014

5. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012;I Williams;HIV Med,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial;The Lancet Global Health;2024-08

2. Linkage to intensive adherence counselling among HIV-positive persons on ART with detectable viral load in Gomba district, rural Uganda;AIDS Research and Therapy;2021-04-20

3. Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania;BMC Infectious Diseases;2020-10-19

4. Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries;Journal of Clinical Microbiology;2020-08-24

5. Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium;Viruses;2020-05-27